Mathias Uhlen research is focused on protein science and precision medicine and ranges from basic research to more applied research, including clinical applications in cancer, infectious diseases, cardiovascular diseases, autoimmune diseases and neurobiology. He leads an international effort to systematically map the human proteome creating an open access resource the Human Protein Atlas (www.proteinatlas.org) with more than 15 million web pages and 10 million annotated bioimages. This resource is now one of the most visited life science databases in the world. His research has resulted in more than 750 publications with more than 80,000 citations and an h-index of 129 (Google Scholar). He is co-founder of 20 biotech companies of which five are publicly traded. He is member of the National Academy of Engineering (NAE) in USA, the Royal Swedish Academy of Science (KVA), the Swedish Academy of Engineering Science (IVA) and the European Molecular Biology Organization (EMBO). He was the Founding Director of the Science for Life Laboratory (SciLifeLab), a Swedish national center for molecular bioscience.